VIJAYALAKSHMI LINGAM: Open Payments
NPI 1760496194 · DETROIT, MI. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$372 in 6 payments from 5 companies in 2025. Trend: 2023 $21 · 2024 $122 · 2025 $372
Food & beverage: $372
| Company | Payments | Amount |
|---|---|---|
| Neurocrine BioSciences, Inc. | 1 | $124 |
| Janssen Pharmaceuticals, Inc | 1 | $110 |
| Luye Pharma (USA) Ltd. | 1 | $71 |
| E.R. Squibb & Sons, L.L.C. | 2 | $45 |
| Vanda Pharmaceuticals Inc. | 1 | $23 |
Products named: INGREZZA, INVEGA SUSTENNA, ERZOFRI EXTENDED-RELEASE, COBENFY, FANAPT.
Industry payments across MI — which companies pay providers there.
